BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3909391)

  • 1. [Reduction of regurgitation in aortic and mitral insufficiency by captopril in acute and long-term trials].
    Heck I; Schmidt J; Mattern H; Fricke G; Kropp J; Reske S
    Schweiz Med Wochenschr; 1985 Nov; 115(45):1615-8. PubMed ID: 3909391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
    Schön HR
    J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.
    Levine HJ; Gaasch WH
    J Am Coll Cardiol; 1996 Nov; 28(5):1083-91. PubMed ID: 8890799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinapril therapy in patients with chronic mitral regurgitation.
    Schön HR; Schröter G; Barthel P; Schömig A
    J Heart Valve Dis; 1994 May; 3(3):303-12. PubMed ID: 8087269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights in the pathophysiology of mitral and aortic regurgitation in pediatric age: role of angiotensin-converting enzyme inhibitor therapy.
    Pisacane C; Pacileo G; Santoro G; Sarubbi B; Iacono C; Russo MG; Calabrò R
    Ital Heart J; 2001 Feb; 2(2):100-6. PubMed ID: 11256536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reduction of regurgitation in aortic insufficiency by inhibition of the renin-angiotensin converting enzyme].
    Reske SN; Kropp J; Heck I; Mattern H; Biersack HJ; Knopp R
    Nuklearmedizin; 1984 Oct; 23(5):241-5. PubMed ID: 6097878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term captopril therapy in asymptomatic patients with severe chronic aortic insufficiency].
    Bisignani G; Serafini O; Caporale R; Guzzo D; Plastina F
    G Ital Cardiol; 1997 Sep; 27(9):925-30. PubMed ID: 9378199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term evaluation of captopril in patients with chronic left sided valvular regurgitations.
    Jirasirirojanakorn K; Mahanonda N; Jootar P; Chaithiraphan S; Wansanit K; Watanaprakarnchai W
    J Med Assoc Thai; 1998 Jan; 81(1):1-9. PubMed ID: 9470315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
    Plante E; Gaudreau M; Lachance D; Drolet MC; Roussel E; Gauthier C; Lapointe E; Arsenault M; Couet J
    Can J Physiol Pharmacol; 2004 Mar; 82(3):191-9. PubMed ID: 15052285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of captopril in chronic aortic insufficiency].
    Klepzig H; Mildenberger D; Baum R; Jungmann E; Standke R; Siede WH; Maul FD; Hör G; Kaltenbach M
    Z Kardiol; 1986 May; 75(5):283-90. PubMed ID: 3526733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Echocardiographic study of left ventricular motion in cases with acute left ventricular diastolic volume overload(author's transl)].
    Hada Y; Sakamoto T; Amano K; Yamaguchi T; Ishimitsu T
    J Cardiogr; 1981 Mar; 11(1):1-12. PubMed ID: 7264377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation.
    Wisenbaugh T; Sinovich V; Dullabh A; Sareli P
    J Heart Valve Dis; 1994 Mar; 3(2):197-204. PubMed ID: 8012639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril mediated decrease of aortic regurgitation.
    Reske SN; Heck I; Kropp J; Mattern H; Ledda R; Knopp R; Winkler C
    Br Heart J; 1985 Oct; 54(4):415-9. PubMed ID: 3902067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation.
    Schön HR; Dorn R; Barthel P; Schömig A
    J Heart Valve Dis; 1994 Sep; 3(5):500-9. PubMed ID: 8000584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic heart failure in patients with mitral and aortic valve defects of rheumatic origin].
    Bagirova GG; Batalina MV
    Ter Arkh; 2000; 72(9):63-6. PubMed ID: 11076422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute haemodynamic effects of nicorandil in patients with chronic severe regurgitant valvular lesions.
    Yadav R; Bhargava B; Aggarwal R; Narang R; Chopra A; Sapra R; Manchanda SC
    Indian Heart J; 1998; 50(2):173-8. PubMed ID: 9622984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydralazine in heart failure.
    Chatterjee K
    Herz; 1983 Aug; 8(4):187-98. PubMed ID: 6413340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of combined aortic regurgitation and systemic hypertension: Insights from an animal model study.
    Couet J; Gaudreau M; Lachance D; Plante E; Roussel E; Drolet MC; Arsenault M
    Am J Hypertens; 2006 Aug; 19(8):843-50. PubMed ID: 16876685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year clinical and echocardiographic follow-up of patients with congestive cardiomyopathy treated with captopril compared to placebo.
    Keren G; Pardes A; Eschar Y; Koifman B; Scherez J; Geleranter I; Laniado S
    Isr J Med Sci; 1994 Jan; 30(1):90-8. PubMed ID: 8138400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.